Sign in
Chemotherapeutic resistance of head and neck squamous cell carcinoma is mediated by EpCAM induction driven by IL-6/p62 associated Nrf2-antioxidant pathway activation
Journal article   Open access  Peer reviewed

Chemotherapeutic resistance of head and neck squamous cell carcinoma is mediated by EpCAM induction driven by IL-6/p62 associated Nrf2-antioxidant pathway activation

Abu Shadat M Noman, Rashed R Parag, Muhammad I Rashid, Shafiqul Islam, Mohammad Z Rahman, Ali A Chowdhury, Afrin Sultana, Chandsultana Jerin, Ayesha Siddiqua, Lutfur Rahman, …
Cell death & disease, Vol.11(8), pp.663-663
20/08/2020
PMID: 32814771

Abstract

Antioxidants - pharmacology Cell Line, Tumor Cisplatin - pharmacology Drug Resistance, Neoplasm - genetics Drug Resistance, Neoplasm - physiology Epithelial Cell Adhesion Molecule - metabolism Epithelial Cell Adhesion Molecule - physiology Gene Expression Regulation, Neoplastic - drug effects Head and Neck Neoplasms - genetics Head and Neck Neoplasms - metabolism Humans Interleukin-6 - metabolism Kelch-Like ECH-Associated Protein 1 - metabolism NF-E2-Related Factor 2 - metabolism NF-E2-Related Factor 2 - physiology Reactive Oxygen Species - metabolism RNA-Binding Proteins - metabolism Signal Transduction - drug effects SOXB1 Transcription Factors Squamous Cell Carcinoma of Head and Neck - genetics Squamous Cell Carcinoma of Head and Neck - metabolism Squamous Cell Carcinoma of Head and Neck - physiopathology
url
https://doi.org/10.1038/s41419-020-02907-xView
Published (Version of record) Open

Metrics

1 Record Views

Details